BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, March 27, 2026
Home
»
Newsletters
» BioWorld
BioWorld
Dec. 11, 2006
View Archived Issues
GSK Acquiring Young Antibody Firm Domantis For $454M Cash
In the latest example of big pharma turning to biotech to beef up its research and development pipelines, GlaxoSmithKline plc agreed to acquire Domantis Ltd. for £230 million (US$454 million) in cash. (BioWorld Today)
Read More
Arena Pharmaceuticals Gets $159M For Stoked Pipeline
Read More
Double Trouble: Malaria, HIV Infection Feed Each Other
Read More
Theravance Submits NDA For Antibiotic Telavancin
Read More
Senate Finally OKs Von Eschenbach As FDA Head
Read More
Other News To Note
Read More
Clinic Roundup
Read More
